Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.

[1]  Yao-Wu Liu,et al.  Effects of Salvianolic Acid A on Plasma and Tissue Dimethylarginine Levels in a Rat Model of Myocardial Infarction , 2013, Journal of cardiovascular pharmacology.

[2]  C. Wanner,et al.  Rosiglitazone Affects Nitric Oxide Synthases and Improves Renal Outcome in a Rat Model of Severe Ischemia/Reperfusion Injury , 2012, PPAR research.

[3]  Y. Tain,et al.  The combined ratios of L-arginine and asymmetric and symmetric dimethylarginine as biomarkers in spontaneously hypertensive rats. , 2012, Translational research : the journal of laboratory and clinical medicine.

[4]  C. Wanner,et al.  Nitric oxide-induced regulation of renal organic cation transport after renal ischemia-reperfusion injury. , 2011, American journal of physiology. Renal physiology.

[5]  C. Wanner,et al.  Low-dose indomethacin after ischemic acute kidney injury prevents downregulation of Oat1/3 and improves renal outcome. , 2009, American journal of physiology. Renal physiology.

[6]  D. Fliser,et al.  PROGRESS IN UREMIC TOXIN RESEARCH: Asymmetric Dimethylarginine and Symmetric Dimethylarginine: Axis of Evil or Useful Alliance? , 2022 .

[7]  S. Clarke,et al.  Protein arginine methylation in mammals: who, what, and why. , 2009, Molecular cell.

[8]  M. Caruso,et al.  Effect of Ischemia–Reperfusion on Renal Expression and Activity of NG-NG-Dimethylarginine Dimethylaminohydrolases , 2008, Anesthesiology.

[9]  C. Baylis.  Nitric oxide deficiency in chronic kidney disease. , 2008, American journal of physiology. Renal physiology.

[10]  Maristela L Onozato,et al.  Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. , 2007, American journal of physiology. Heart and circulatory physiology.

[11]  L. Ignarro,et al.  The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio. , 2007, Pharmacology & therapeutics.

[12]  E. Schwedhelm,et al.  High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  J. Zweier,et al.  Evidence for the Pathophysiological Role of Endogenous Methylarginines in Regulation of Endothelial NO Production and Vascular Function* , 2007, Journal of Biological Chemistry.

[14]  D. Schwartz,et al.  Tubular and Glomerular L-Arginine Transport (Uptake and Transporters) and the Nitric Oxide Synthases in Ischemic Acute Renal Failure (iARF) in Streptozotocin-Induced Diabetic Rats (STZ-DM) , 2007, Renal failure.

[15]  F. Grimminger,et al.  Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[16]  J. Cooke,et al.  Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  T. Imaizumi,et al.  Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[18]  G. Breithardt,et al.  Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. , 2006, Journal of the American Society of Nephrology : JASN.

[19]  E. Closs,et al.  Structure and Function of Cationic Amino Acid Transporters (CATs) , 2006, The Journal of Membrane Biology.

[20]  G. Wolf,et al.  Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease – possible candidates for paradoxical epidemiology? , 2006, Amino Acids.

[21]  John A Kellum,et al.  Acute renal failure in critically ill patients: a multinational, multicenter study. , 2005, JAMA.

[22]  R. Schrier,et al.  Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. , 2004, The Journal of clinical investigation.

[23]  H. Prins,et al.  Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  C. Wanner,et al.  L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats. , 2003, Kidney international.

[25]  H. Kosaka,et al.  Induction of LOX‐1 and iNOS expressions by ischemia‐reperfusion of rat kidney and the opposing effect of L‐arginine , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  D. Schwartz,et al.  L-Arginine transport is augmented through up-regulation of tubular CAT-2 mRNA in ischemic acute renal failure in rats. , 2002, Kidney international.

[27]  K. Lopau,et al.  L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation. , 2002, Kidney international.

[28]  M. Goligorsky,et al.  Nitric oxide in acute renal failure: NOS versus NOS. , 2002, Kidney international.

[29]  C. Zoccali,et al.  Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study , 2001, The Lancet.

[30]  L. Wagner,et al.  Uremic levels of urea inhibit L-arginine transport in cultured endothelial cells. , 2001, American journal of physiology. Renal physiology.

[31]  A. Belló-Klein,et al.  Role of the L-arginine/nitric oxide pathway in renal ischaemia-reperfusion in rats. , 2001, The European journal of surgery = Acta chirurgica.

[32]  D. Tsikas,et al.  Endogenous nitric oxide synthase inhibitors are responsible for the L‐arginine paradox , 2000, FEBS letters.

[33]  H R Herschman,et al.  PRMT1 Is the Predominant Type I Protein Arginine Methyltransferase in Mammalian Cells* , 2000, The Journal of Biological Chemistry.

[34]  R. D'Hooge,et al.  N G , N G -Dimethylarginine and N G , N ' G -dimethylarginine in renal insufficiency , 2000 .

[35]  R. D'Hooge,et al.  NG,NG-Dimethylarginine and NG,N'G-dimethylarginine in renal insufficiency , 2000, Pflügers Archiv.

[36]  E. Block,et al.  A Caveolar Complex between the Cationic Amino Acid Transporter 1 and Endothelial Nitric-oxide Synthase May Explain the “Arginine Paradox”* , 1997, The Journal of Biological Chemistry.

[37]  U. Förstermann,et al.  Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B. , 1997, Nitric oxide : biology and chemistry.

[38]  M. Kimoto,et al.  Occurrence of a new enzyme catalyzing the direct conversion of NG,NG-dimethyl-L-arginine to L-citrulline in rats. , 1987, Biochemical and biophysical research communications.